News

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
A combination covid-19/flu vaccine could make it easier for people to get protection from both diseases. © Stockpot Videos via Shutterstock Moderna’s mRNA-based ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.
The trial found that antibody levels were higher for COVID and all but one flu strain in those who got the combo.
The Trump administration is planning to drop recommendations that pregnant women, teenagers and children get Covid-19 ...
While sales of its COVID-19 vaccine continue to decline as expected in a post-pandemic market, Moderna is taking proactive steps to reshape its future. The company is swiftly advancing multiple ...
Moderna (MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and prioritization programs amid declining sales of its Covid shots.
However, they traced his symptoms back a week after the elderly patient had received his Moderna Covid vaccine booster - marking it as his fifth shot. The experts theorized that it was ...
Moderna’s new combination vaccine for seasonal influenza and COVID-19 has outperformed current standard vaccines in a large phase 3 clinical trial, showing stronger immune responses to both viruses in ...